Accessibility Menu
Co-Diagnostics logo

Co-Diagnostics

(NASDAQ) CODX

Current Price$4.14
Market Cap$15.81M
Since IPO (2017)-98%
5 Year-100%
1 Year-98%
1 Month+168%

Co-Diagnostics Financials at a Glance

Market Cap

$15.81M

Revenue (TTM)

$718.17K

Net Income (TTM)

-$48.50M

EPS (TTM)

-$28.01

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$4.14

Volume

10,694

Open

$4.58

Previous Close

$4.14

Daily Range

$3.89 - $4.95

52-Week Range

$1.26 - $1,395.00

Estimated Earnings Date

Aug 14, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Co-Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

115

CEO

Dwight Howard Egan

Website

co-dx.com

Headquarters

Salt Lake City, UT 84109, US

CODX Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

-44%

Net Income Margin

-68%

Return on Equity

-152%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.81M

Shares Outstanding

3.69M

Volume

10.69K

Avg. Volume

6.46M

Financials (TTM)

Gross Profit

$400.11K

Operating Income

-$31.28M

EBITDA

-$47.41M

Operating Cash Flow

-$29.14M

Capital Expenditure

-$700.05K

Free Cash Flow

-$29.84M

Cash & ST Invst.

$11.88M

Total Debt

$1.24M

Co-Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$145.95K

+190.3%

Gross Profit

-$303.26K

-1157.1%

Gross Margin

-2.08%

N/A

Market Cap

$15.81M

N/A

Market Cap/Employee

$119.77K

N/A

Employees

132

N/A

Net Income

-$9.14M

-21.3%

EBITDA

-$8.88M

-22.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$8.23M

-61.7%

Total Debt

$2.03M

+5.1%

Accounts Receivable

$82.39K

-39.6%

Inventory

$846.12K

-21.9%

Long Term Debt

$1.17M

+14.0%

Short Term Debt

$857.64K

-5.0%

Return on Assets

-2.26%

N/A

Return on Invested Capital

-1.86%

N/A

Free Cash Flow

-$7.99M

+9.6%

Operating Cash Flow

-$7.85M

+10.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ADGMAdagio Medical Holdings, Inc.
$0.75-3.50%
SINTSintx Technologies, Inc.
$2.12-4.07%
TNONTenon Medical, Inc.
$0.62-0.99%
VVOSVivos Therapeutics, Inc.
$0.57-6.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About CODX

What is the current price of Co-Diagnostics?

Co-Diagnostics is trading at $4.14 per share.

What is the 52-week range for Co-Diagnostics?

Over the past 52 weeks, Co-Diagnostics has traded between $1.26 and $1,395.00.

How much debt does Co-Diagnostics have?

As of the most recent reporting period, Co-Diagnostics reported total debt of $2.03M.

How much cash does Co-Diagnostics have on hand?

Co-Diagnostics reported $8.23M in cash and cash equivalents in its most recent financial results.

What is Co-Diagnostics’s dividend yield?

Co-Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.